Date: 2015-05-06
Type of information: Nomination
Compound:
Company: ImmuPharma (UK)
Therapeutic area: Autoimmune diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On May 6, 2015, ImmuPharma, the specialist drug discovery and development company, announcedthat Dr Franco Di Muzio, senior Non-Executive Director will take on the role of Chairman on an interim basis. Due to recent ill health, Richard Warr, Executive Chairman, has taken a leave of absence in order to make a full recovery.
Financial terms:
Latest news:
